Ultimo aggiornamento :
19/11/2024
Antibiotico   Cefamandole nafate  
Iniezione
Stabilità in soluzione Stabilità in miscela Fattori che influenzano la stabilità Compatibilità metodo di iniezione Bibliografia pdf
   Struttura chimica  

Nome commerciale   Nome commerciale     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Acemycin Grecia
Cefam Italia, Ungheria
Cefamandol Lussemburgo
Cefamandolo Italia
Cemado Italia
Kefadol Irlanda
Kefandol Gran Bretagna, Marocco
Lampomandol Italia
Mancef Italia
Mandokef Austria, Grecia, Italia, Svizzera, Ungheria
Mandol Australia, Emirati Arabi Uniti, Lussemburgo, nuova Zelanda, Paesi Bassi
Mandolsan Italia
Septomandolo Italia
Tarcefandol Polonia
Bibliografia   Iniezione   Bibliografia : Cefamandole nafate  
tipo pubblicazione
198 Rivista Gayed AA, Kheshary PR, Hinkle RL.
Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection.
Am J Health-Syst Pharm 1995 ; 52: 516-520.
336 Rivista Forman JK, Lachs JR, Souney PF.
Visual compatibility of acyclovir sodium with commonly used intravenous drugs during simulated Y-site injection.
Am J Hosp Pharm 1987 ; 44: 1408-1409.
385 Rivista Benedict MK, Roche VF, Banakar UV, Hilleman DE.
Visual compatibility of amiodarone hydrochloride with various antimicrobial agents during simulated Y-site injection.
Am J Hosp Pharm 1988 ; 45: 1117-1118.
405 Rivista Nieves-Cordero AL, Luciw HM, Souney PF.
Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection.
Am J Hosp Pharm 1985 ; 42: 1108-1109.
406 Rivista Smythe MA, Patel MA, Gasloli RA.
Visual compatibility of narcotic analgesics with selected intravenous admixtures.
Am J Hosp Pharm 1990 ; 47: 819-820.
418 Rivista Bosso JA, Townsend RJ.
Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitine sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions.
Am J Hosp Pharm 1985 ; 42: 2211-2214.
472 Rivista Wohlford JG, Fowler MD.
Visual compatibility of hetastarch with injectable critical-care drugs.
Am J Hosp Pharm 1989 ; 46: 995-996.
574 Rivista Kleinberg ML, Stauffer GL, Prior RB, Latiolais CJ.
Stability of antibiotics frozen and stored in disposable hypodermic syringes.
Am J Hosp Pharm 1980 ; 37: 1087-1088.
576 Rivista Holmes CJ, Ausman RK, Walter CW, Kundsin RB.
Activity of antibiotic admixtures subjected to different freeze-thaw treatments.
Drug Intell Clin Pharm 1980 ; 14: 353-357.
604 Laboratorio Stabilité des médicaments dans l'Intermate® SV50, 100, 200
Baxter 1998
612 Rivista Frable RA, Klink PR, Engel GL, Mundell EE.
Stability of cefamandole nafate injection with parenteral solutions and additives.
Am J Hosp Pharm 1982 ; 39: 622-627.
630 Rivista Das Gupta V, Stewart KR.
Stability of metronidazole and ten antibiotics when mixed with magnesium sulphate solutions.
J Clin Hosp Pharm 1985 ; 10: 67-72.
999 Rivista Watson D.
Piggyback compatibility of antibiotics with pediatric parenteral nutrition solution.
JPEN 1985 ; 9: 220-224.
1035 Rivista Bisaillon S, Sarrazin R.
Compatibility of several antibiotics or hydrocortisone when added to metronidazole solution for intravenous infusion.
J Parenter Sci Technol 1983 ; 37: 129-132.
1047 Rivista Souney PF, Colucci RD, Mariani G, Campbell D.
Compatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injection.
Am J Hosp Pharm 1984 ; 41: 323-324.
1057 Rivista Cutie MR.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Am J Hosp Pharm 1983 ; 40: 1205-1207.
1165 Rivista Bowtle WJ, Heasman MJ, Prince AP, Easthope DA.
Compatibility of the cephalosporin, cefamandole nafate with injections.
Int J Pharm 1980 ; 4: 263-265.
1201 Rivista Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG.
Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures.
Am J Hosp Pharm 1981 ; 38: 1919-1922.
1232 Rivista Beatson C, Taylor A.
A physical compatibility study of furosemide & flucloxacillin injections.
Br J Pharm Pract 1987 ; 9: 223-226, 236.
1479 Rivista Digel S.
Cefamandolnafat und metronidazol. Chemische stabilität in einer mischung zur intravenösen infusion.
Krankenhauspharmazie 1995 ; 1: 9-12.
3520 Laboratorio Cidomycin - Summary of product Chracteristics.
Sanofi 2011
3526 Laboratorio Clindamycin (Dalacin®) - Summary of Product Characteristics
Pharmacia 2010
3546 Laboratorio Cefamandole Flavelab - Résumé des caractéristiques du produit
Panpharma SA 2007
3549 Laboratorio Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3594 Laboratorio Metronidazole (Flagyl®) - Summary of Product Characteristics
Zentiva 2013
3643 Laboratorio Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
3644 Laboratorio Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
3674 Laboratorio Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016

  Mentions Légales